Patients Diagnosed With Cancer
Conditions
Keywords
Aromatherapy, Foot bath, Pain, Fatigue, Sleep quality
Brief summary
The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question\[s\] it aims to answer are: * Is an aromatherapy foot bath effective in reducing pain in cancer patients? * Is an aromatherapy foot bath effective in improving sleep quality in cancer patients? * Is an aromatherapy foot bath effective in reducing fatigue in cancer patients? The experimental group will receive a total of 5 sessions of aromatherapy foot baths, each lasting 20 minutes per day for 5 days, administered by the researcher. The control group will receive only routine care without any treatment. Before and after all treatments are completed, participants will be given and asked to complete the Hirai Cancer Fatigue Scale, the Pittsburgh Sleep Quality Index (PSQI), and the Numerical Pain Scale. The pain, fatigue, and sleep quality scores of the experimental and control groups will then be compared.
Interventions
OTHERAromatherapy
The experimental group will receive a foot bath treatment containing aromatherapy for 5 days administered by the researcher. A foot bath device will be used. Lavender essential oil will be added to the water as aromatherapy. Then, the researcher will administer a foot bath to the patient using this water.
Sponsors
Ankara Yildirim Beyazıt University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients over 18 years of age, * Conscious (Glasgow coma scale: 15 points) * No diagnosis of mental illness * No respiratory distress * No diagnosis of respiratory system disorder * Patients who agree to participate in the study
Exclusion criteria
* Patients under 18 years of age, * Patients with a Glasgow Coma Scale score below 15 points, * Patients with a diagnosis of mental illness, * Patients with respiratory distress, * Patients with a diagnosis of respiratory system disease, * Patients with hemiplegia or paraplegia, * Patients who refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hirai Cancer Fatigue Scale | Baseline and day 5 | The scale has a minimum score of 15 and a maximum score of 75. Higher scores indicate increased fatigue, while lower scores indicate decreased fatigue. |
| Numerical Pain Scale | Baseline and day 5 | Participants will be asked to rate the intensity of their pain on a scale of 0 (no pain) to 10 (most severe pain). A higher score indicates increasing pain. |
| Pittsburgh Sleep Quality Index | Baseline and day 5 | The total score ranges from 0 to 21. A total score higher than 5 indicates poor sleep quality. |
Contacts
CONTACTErdal Ceylan
PRINCIPAL_INVESTIGATORSemra Gündoğdu
Ankara Yildirim Beyazıt University
STUDY_DIRECTORErdal Ceylan
Ankara Yildirim Beyazıt University
STUDY_CHAIRAhmet Özgen Yıldırım
Ankara Etlik City Hospital
Outcome results
None listed